Thromboembolic events at the time of highly active antiretroviral therapies against human immunodeficiency virus;Événements thromboemboliques à l'ère des trithérapies antirétrovirales hautement actives contre le virus de l'immunodéficience humaine

Revue de Medecine Interne

Volumn 29, Issue 2, 2008, Pages 100-104

  Lyonne, L ^a   Magimel, C ^a   Cormerais, L ^a   Trouillier, S ^a   Bocquier, B ^a   Zenut, M ^b   Jacomet, C ^a   Laurichesse, H ^a   Beytout, J ^a   Lesens, O ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

HAART; HIV; Lopinavir ritonavir; Pulmonary embolism; Venous thrombosis

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; AMLODIPINE; ANTIVITAMIN K; ATENOLOL; DIDANOSINE; EFAVIRENZ; FLUINDIONE; HEPARIN; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; PRAVASTATIN; RITONAVIR; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LOPINAVIR; PROTEINASE INHIBITOR; PYRIMIDINONE DERIVATIVE;

ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; THROMBOEMBOLISM; VEIN THROMBOSIS; CASE REPORT; COHORT ANALYSIS; FRANCE; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HIV PROTEASE INHIBITORS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; PYRIMIDINONES; RETROSPECTIVE STUDIES; RITONAVIR; VENOUS THROMBOSIS;

EID: 38649123031     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.10.417     Document Type: Article

References (25)

1. Shen Y.M., and Frenkel E.P. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost 10 (2004) 277-280
2. Saif M.W., Bona R., and Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 15 (2001) 311-320
3. Saber A.A., Aboolian A., LaRaja R.D., Baron H., and Hanna K. HIV/AIDS and the risk of deep vein thrombosis: a study of 45 patients with lower extremity involvement. Am Surg 67 (2001) 645-647
4. Majluf-Cruz A., Silva-Estrada M., Sanchez-Barboza R., Montiel-Manzano G., Trevino-Perez S., Santoucoy-Gomez M., et al. Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost 10 (2004) 19-25
5. Pulik M., Lionnet F., Couderc L.J., Matheron S., and Saimot A.G. Thromboembolic disease and human immunodeficiency virus infection. Blood 82 (1993) 2931
6. Loire R., and Capron L. Vascular complications of HIV infection. Sang Thromb Vaiss 7 (1995) 487-492
7. Copur A.S., Smith P.R., Gomez V., Bergman M., and Homel P. HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS 16 (2002) 205-209
8. Wang X., Chai H., Yao Q., and Chen C. Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defic Syndr 44 (2007) 493-499
9. George S.L., Swindells S., Knudson R., and Stapleton J.T. Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of seven cases. Am J Med 107 (1999) 624-630
10. Carr A., Brown D., and Cooper D.A. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. Aids 11 (1997) 1657-1658
11. Bégaud B., Evreux J.C., Jouglard J., and Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 40 (1985) 111-118
12. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
13. Naess I.A., Christiansen S.C., Romundstad P., Cannegieter S.C., Rosendaal F.R., and Hammerstrom J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 5 (2007) 692-699
14. Nordström M., Lindblad B., Bergqvist D., and Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 232 (1992) 155-160
15. Toulon P., Blanche Ph, Bachmeyer C., Gorin I., Sereni D., and Sicard D. Thromboembolism and HIV infection. Protein S and hypoalbuminemia as risk factors for thrombosis. Blood 84 Suppl 1 (1994) 481a
16. Bissuel F., Berruyer M., Causse X., Dechavanne M., and Trepo C. Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr 5 (1992) 484-489
17. Cohen J.R., Lackner R., Wenig P., and Pillari G. Deep venous thrombosis in patients with AIDS. N Y State J Med 90 (1990) 159-161
18. Klein S.K., Slim E.J., de Kruif M.D., Keller T.T., ten Cate H., van Gorp E.C., et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med 63 (2005) 129-136
19. Saif M.W., and Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS 15 (2001) 15-24
20. Toulon P., Lamine M., Ledjev I., Guez T., Holleman M.E., and Sereni D. Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus. Thromb Haemost 70 (1993) 730-735
21. Erbe M, Rickerts V, Bauersachs RM, Lindhoff-Last E. Acquired protein C and protein S deficiency in HIV-infected patients. Clin Appl Thromb Hemost 2003; 9:325-
22. Levine A.M., Vigen C., Gravink J., Mack W., Watts C.H., and Liebman H.A. Progressive prothrombotic state in women with advancing HIV disease. J Acquir Immune Defic Syndr 42 (2006) 572-577
23. Dillmon M.S., Saag M.S., Hamza S.H., Adler B.K., and Marques M.B. Unusual thrombosis associated with protein S deficiency in patients with acquired immunodeficiency syndrome: case reports and review of the literature. AIDS Res Hum Retroviruses 21 (2005) 753-756
24. Bloom E.J., Abrams D.I., and Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 256 (1986) 491-493
25. Ramanampamonjy R.M., Ramarozatovo L.S., Bonnet F., Lacoste D., Rambeloarisoa J., Bernard N., et al. Portal vein thrombosis in HIV-infected patients: report of four cases. Rev Med Interne 26 (2005) 545-548